Marketing Internship in Infectious Diseases Division – France
Job posted on: November 21, 2025 The Infectious Diseases Division of a global healthcare leader is offering a Marketing Internship […]
Job posted on: November 21, 2025 The Infectious Diseases Division of a global healthcare leader is offering a Marketing Internship […]
On November 22, 2025, the FDA released details regarding a significant recall of the i-View Video Laryngoscope, manufactured by Intersurgical
Medline Industries, LP has issued an urgent revision to the use instructions for Medline medical convenience kits containing the Flexicare
On November 22, 2025, Swissmedic published an important regulatory update announcing the first authorisation of Lutathera®, a therapeutic option designed
On November 22, 2025, Swissmedic announced the extension of the therapeutic indication for Breyanzi® (lisocabtagene maraleucel). This change has important
On November 22, 2025, Swissmedic officially granted the first authorization of 18F-PSMA-1007 ZRP®. This approval represents an important milestone in
Swissmedic has announced the first authorisation of Radelumin®, marking a significant regulatory achievement. Effective November 22, 2025, this authorisation introduces
Swissmedic, Switzerland’s medical regulatory authority, has announced an important update regarding NexoBrid®. On November 22, 2025, Swissmedic extended the therapeutic
On November 22, 2025, Swissmedic released a Direct Healthcare Professional Communication (DHPC) concerning DIBASE® 10’000 (cholecalciferolum). This announcement highlights crucial
Health Canada has published updated guidelines for managing medical device license applications. These regulations aim to enhance clarity for manufacturers,